Iovance receives FDA clearance for IL-12 tethered TIL therapy trial
Go back to Iovance receives FDA clearance for IL-12 tethered TIL therapy trial| (NASDAQ: IOVA) | Delayed: 4.38 +0.59 (15.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.79 | 52 Week High | $ | |||
| Open | $3.85 | 52 Week Low | $ | |||
| Day High | $4.58 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $ | |||
| Volume | 22,599,966 | |||||

